Table 2.
Composite of morbidity in relation to tertile distribution of the baseline HMGB1 concentration.
| Total(n = 250) | First Tertile (n = 83)(0.001–0.348 ng/ml) | Second Tertile (n = 83)(0.351–0.967 ng/ml) | Third tertile (n = 84)(0.982–47.799 ng/ml) | P value | |
|---|---|---|---|---|---|
| HMGB1, ng/ml | 0.620 [0.268–1.551] | 0.187 [0.095–0.269] | 0.620 [0.483–0.816]* | 3.144 [1.520–7.584]*† | <0.001 |
| Composite morbidity, n (%) | 58 (23) | 16 (19) | 22 (27) | 20 (24) | 0.537 |
| Death, n (%) | 10 (4) | 4 (5) | 4 (5) | 2 (2) | 0.669 |
| Stroke, n (%) | 4 (2) | 3 (4) | 1 (1) | 0 | 0.131 |
| Myocardial infarction, n (%) | 0 (0) | — | |||
| Renal failure, n (%) | 29 (12) | 9 (11) | 13 (16) | 7 (8) | 0.338 |
| Prolonged ventilation> 24 h | |||||
| Number, n (%) | 33 (13) | 6 (7) | 11 (13) | 16 (19) | 0.082 |
| Duration (hrs) | 17 [14–21] | 17 [12–20] | 18 [15–22] | 18 [15–22] | 0.251 |
Values are expressed as the numbers of patients (%), median [interquartile range]. *P < 0.05 vs. first tertile; †P < 0.05 vs. second tertile.
HMGB1 = High mobility group box 1.